Literature DB >> 25551263

Variability of the aging process in dementia-free adults with Down syndrome.

Raphaele Tsao, Cecile Kindelberger, Benedicte Fréminville, Renaud Touraine.   

Abstract

The aim of this cross-sectional study was to analyze the typical aging process in adults with Down syndrome, focusing on its variability. The sample comprised 120 adults with Down syndrome who were free of dementia. Ages ranged from 20 to 69 years. Each participant was assessed on cognitive functioning and social adaptation, and was checked for the presence of psychopathological disorders. Results revealed an age-related deterioration in both cognitive and social adaptation skills, the extent of this decline depending on the dimension under scrutiny, and interindividual variability in aging profiles.

Entities:  

Keywords:  Down syndrome; aging; cognitive functioning; social adaptation

Mesh:

Year:  2015        PMID: 25551263     DOI: 10.1352/1944-7558-120.1.3

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  3 in total

1.  Down syndrome with posterior cortical atrophy.

Authors:  Claire Boutoleau-Bretonnière; Amandine Pallardy
Journal:  BMJ Case Rep       Date:  2018-02-08

2.  Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB).

Authors:  Amanda Sinai; Angela Hassiotis; Khadija Rantell; Andre Strydom
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

3.  The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.

Authors:  Alain D Dekker; Silvia Sacco; Angelo Carfi; Bessy Benejam; Yannick Vermeiren; Gonny Beugelsdijk; Mieke Schippers; Lyanne Hassefras; José Eleveld; Sharina Grefelman; Roelie Fopma; Monique Bomer-Veenboer; Mariángeles Boti; G Danielle E Oosterling; Esther Scholten; Marleen Tollenaere; Laura Checkley; André Strydom; Gert Van Goethem; Graziano Onder; Rafael Blesa; Christine Zu Eulenburg; Antonia M W Coppus; Anne-Sophie Rebillat; Juan Fortea; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.